Flagship Biotech International Private Limited
Indian Pharmaceutical Exporter ยท Advanced Antibiotics Specialist ยท $429.3K Total Trade ยท DGFT Verified
Flagship Biotech International Private Limited is an Indian pharmaceutical exporter with a total trade value of $429.3K across 4 products in 4 therapeutic categories. Based on 23 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Teicoplanin ($250.0K), Levamisole ($75.0K), Antitoxin ($53.7K).
Flagship Biotech International Private Limited โ Export Portfolio & Destination Treemap

Who is Flagship Biotech International Private Limited? โ Company Overview & Market Position
Flagship Biotech International Private Limited, established in August 2011, is a privately held pharmaceutical company headquartered in Navi Mumbai, Maharashtra, India. The company specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations, including tablets, capsules, syrups, and injections. With an authorized capital of โน1.08 crore and a paid-up capital of โน13.26 lakh, Flagship Biotech has demonstrated consistent growth and financial stability.
Over the years, Flagship Biotech has expanded its global footprint, operating in more than 75 countries worldwide. The company's extensive product portfolio encompasses over 700 pharmaceutical formulations across various therapeutic areas, such as oncology, anti-diabetic, cardiology, pain management, gynecology, anti-infectives, vitamins, minerals, nutrients, gastrointestinal, anti-osteoporosis, anti-malarial, immunosuppressants, anti-bacterial, anti-asthmatics, and anti-allergy.